Spero Therapeutics (SPRO) Earnings Date & Reports

Industry: @Pharmaceuticals Major

A.I. Advisor

published Earnings

SPRO is expected to report earnings to fall 25.24% to -24 cents per share on November 06

Spero Therapeutics SPRO Stock Earnings Reports

Q3'24

Est.

$-0.25

Q2'24

Beat

by $0.05

Q1'24

Missed

by $0.12

Q4'23

Beat

by $1.02

Q3'23

Missed

by $0.03

The last earnings report on August 05 showed earnings per share of -33 cents, beating the estimate of -37 cents. With 105.44K shares outstanding, the current market capitalization sits at 70.80M.

View a ticker or compare two or three

Compare

SPRO

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For SPRO
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of novel therapies for the treatment of resistant bacterial infections

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

675 Massachusetts Avenue

Phone

+1 857 242-1600

Employees

Web

https://www.sperotherapeutics.com